Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
References Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds
Accounts for up to 30% of reported 'non-responder' cases in peptide research protocols
No single number applies to every patient
TB-500 is a truncated version of thymosin beta 4 and is receiving increasing attention for its healing properties 2
Zhang, W., et al
The elevation in the Ang I/Ang II ratio could be related to decreased production of Ang II, due to reduced angiotensin-converting enzyme (ACE) activity, or increased degradation of Ang II, either by ACE type 2 or, as recently suggested, by peptidases, such as dipeptidyl peptidase 3 (DPP3) [8, 11,12,13]
